Quick Comparison

Alpha ArbutinKojic Acid
Typical ConcentrationConcentrations: 1-2%. Apply morning and/or night. Can be combined with vitamin C and niacinamide for enhanced brightening. Results visible at 8-12 weeks. More effective when combined with acids or retinoids that increase cell turnover.Concentrations: 1-4%. Kojic dipalmitate is a more stable ester form but less potent. Apply once or twice daily. Often combined with other brightening agents (arbutin, vitamin C, niacinamide). Results visible at 4-8 weeks.
ApplicationTopical (serum, cream). Water-soluble. Apply before oils/occlusives.Topical (serum, cream). Store in airtight, opaque packaging. Discard if the product turns brown.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Alpha Arbutin

Alpha arbutin (4-hydroxyphenyl-alpha-D-glucopyranoside) is a glycosylated hydroquinone with glucose bound to the para position. Alpha-glucosidase and other glycosidases slowly hydrolyze the bond, releasing hydroquinone in controlled low concentrations—avoiding peak levels that cause irritation and ochronosis. Released hydroquinone inhibits tyrosinase by competing with tyrosine and through copper chelation at the catalytic center, reducing L-DOPA to dopaquinone conversion. The alpha anomer provides greater stability and skin penetration than beta arbutin. May also inhibit melanosome maturation. Gradual release creates sustained low-dose tyrosinase inhibition that brightens over 8-12 weeks with minimal side effects.

Kojic Acid

Kojic acid (5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) inhibits tyrosinase through copper chelation—tyrosinase is a type-3 copper enzyme requiring two copper ions to catalyze tyrosine to L-DOPA and L-DOPA to dopaquinone. By sequestering copper, kojic acid renders tyrosinase inactive. May also inhibit tyrosinase-related protein-1 (TRP-1). Exhibits direct antioxidant activity, scavenging superoxide and hydroxyl radicals. Relatively unstable—oxidizes with air and light, forming brown degradation products that lose activity; opaque, airtight packaging and low pH improve stability. Kojic dipalmitate is a more stable ester but requires enzymatic cleavage, reducing potency. Contact sensitization can develop with prolonged use.

Risks & Safety

Alpha Arbutin

Common

Very well-tolerated. Occasionally mild irritation.

Serious

None documented at cosmetic concentrations.

Rare

Allergic contact dermatitis.

Kojic Acid

Common

Contact sensitization (developing an allergy over time with repeated use), redness, irritation.

Serious

Contact dermatitis in sensitized individuals.

Rare

Paradoxical darkening in very sensitive skin types.

Full Profiles